Evidence map›Paper›PMID 42345324›Full record

ArticleAnalytical chemistry2026

In-Depth Characterization of PEGylated Liposomes: Using AF4 and HPLC-CAD in Tandem as a Strategy for Composition Assessment and Postinsertion Optimization.

Silvia L Appleton, Guillaume Bucher, Jessica Ponti, Dora Mehn

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Silvia L AppletonEuropean Commission, Joint Research Centre (JRC), Ispra 21027, Italy.ORCID 0000-0003-2149-2596
Guillaume BucherEuropean Commission, Joint Research Centre (JRC), Ispra 21027, Italy.ORCID 0000-0002-3228-0639
Jessica PontiEuropean Commission, Joint Research Centre (JRC), Ispra 21027, Italy.
Dora MehnEuropean Commission, Joint Research Centre (JRC), Ispra 21027, Italy.ORCID 0000-0003-3482-2996

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The surface of nanoparticles for pharmaceutical use is crucial as it is the first interface that interacts with the biological environment in the body and therefore determines the fate of the nanoparticle itself. Aware of its key role, regulatory agencies urgently require rigorous quality control of the surface, including polyethylene glycol (PEG) coatings, a component widely used in nanomedicine, which is also present in recent vaccines against SARS-CoV-2, to ensure efficacy and safety. Building on a review of the literature and experimental testing, this study proposes a workflow to overcome critical issues related to liposome PEG coating. It integrates microfluidic synthesis with PEG postinsertion, using mild incubation conditions and a straightforward quality control analysis for method efficiency and reliability. Using multidetector Asymmetric-Flow Field-Flow Fractionation (AF4-MD) in combination with High-Performance Liquid Chromatography coupled to a Charged Aerosol Detector (HPLC-CAD) proved to be an efficient strategy for analyzing simultaneously both the size distribution and other size-dependent parameters with special attention on the precise composition of PEGylated liposomes. By exploiting the AF4 size separation of PEGylated liposomes from unincorporated PEG-lipid micelles, this approach enables the optimization of postinsertion reaction conditions and the validation of traditional purification methods. This comprehensive workflow allows for in-depth liposome characterization, focusing on critical quality attributes. It includes reliable and straightforward PEG coating determination, essential for postinsertion tuning, and offers potential adaptability to other stealth coatings, thus providing a valuable reference for nanomedicine developers, control laboratories, and regulatory bodies.

Indexed as

Fractionation, Field FlowLiposomesPolyethylene GlycolsChromatography, High Pressure LiquidParticle SizeLiposomesPolyethylene Glycols

Identifiers

PMID42345324
PMCPMC13347696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.